Descrizione del progetto
Dispositivo indossabile di nuova generazione per gli atleti
I dispositivi sanitari indossabili sono una tecnologia emergente che modifica l’approccio del monitoraggio sanitario. Consentendo l’auto-monitoraggio della salute e una gestione proattiva della salute, gli atleti si rivolgono anche a sensori indossabili per monitorare le loro prestazioni, infortuni e tempi di recupero. Il progetto Smart Tracker, finanziato dall’UE, sta introducendo sul mercato il pacchetto Caura, il primo tracker molecolare che misura il lattato e il glucosio in tempo reale per rivelare la firma molecolare del corpo. Per gli atleti, fornisce preziose informazioni sull’allenamento, su come si comporta il loro corpo per evitare l’esaurimento. Il monitoraggio non invasivo, wireless e continuo del glucosio e del lattato aiuta gli atleti a identificare quale dieta funziona meglio e il momento ottimale per allenarsi. Il pacchetto Caura si avvale della nuova tecnologia microneedle, un tracker digitale economico e sofisticati algoritmi di apprendimento automatico.
Obiettivo
Wearable biosensor systems for fitness and health monitoring have become popular in the last years, however, there is no
wearable technology currently available for accurately monitor key biometrics that directly reflect one’s body performance
(i.e. glucose and lactate) with clinical precision. In turn, Caura project aims at providing the first molecular tracker which
unlocks anyone’s molecular signature. It will give instant and real-time feedback on lifestyle and health, while providing
unmatched training insights and effective dietary plans through non-invasive, wireless and continuous glucose and lactate
monitoring. The invention relies on their cutting-edge microneedle technology, a cost-effective digital tracker plus
sophisticated machine learning algorithms allowing accurate and real-time glucose and lactate measurements for the first
time on the individual’s skin and under free living conditions. Caura will result on added value for high-quality wearables,
improving athletic performance and sport medicine by enabling ubiquitous monitoring of those biometrics. Other valuable
novelties are its reduced cost and dimensions compared to the available options. These advantages make Caura a
disruptive solution with great potential for commercial success in the growing wearables market (€285B by 2022, CAGR
12.5%), representing a core source of growth for the company and consolidating the Company position in the bio-sensing
sector. The Company will conduct a feasibility study and a business plan analyzing the technical, commercial and financial
aspects required to ensure the market launch. Being glucose and lactate important vital parameters also involved in some of
the biggest health issues (e.g. diabetes, obesity etc.), Caura will transition from simple recreational tracker to life-changing
tool focusing on individual’s lifestyle and health, enabling for the necessary transformation towards a person-centred
preventive health care system.
Campo scientifico
- engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsbiosensors
- natural sciencescomputer and information sciencesinternetinternet of things
- social scienceseconomics and businessbusiness and managementbusiness models
- natural sciencescomputer and information sciencesartificial intelligencemachine learning
- medical and health scienceshealth sciencesnutritionobesity
Programma(i)
Argomento(i)
Invito a presentare proposte
Vedi altri progetti per questo bandoBando secondario
H2020-SMEInst-2018-2020-1
Meccanismo di finanziamento
SME-1 - SME instrument phase 1Coordinatore
SW1P 2QW LONDON
Regno Unito
L’organizzazione si è definita una PMI (piccola e media impresa) al momento della firma dell’accordo di sovvenzione.